Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group

Andre, T ; Vernerey, D ; Im, SA ; Bodoky, G ; Buzzoni, R ; Reingold, S ; Rivera, F ; McKendrick, J ; Scheithauer, W ; Ravit, G ; Fountzilas, G ; Yong, WP ; Isaacs, R ; Osterlund, P ; Liang, JT ; Creemers, GJ ; Rakez, M ; Van Cutsem, E ; Cunningham, D ; Tabernero, J ; de Gramont, A

Oxford University Press (OUP) 2020-02

Texto completo disponível